SMT201600219B - IMPROVED HUMAN FOLLICLE-STIMULATING HUMAN HORMONE - Google Patents

IMPROVED HUMAN FOLLICLE-STIMULATING HUMAN HORMONE

Info

Publication number: SMT201600219B
Authority: SM; San Marino
Prior art keywords: human; hormone; stimulating; follicle; improved
Prior art date: 2010-08-04

Application number

SM201600219T

Other languages

Italian (it)

Inventor

Steffen Goletz

Lars Stöckl

Original Assignee

Glycotope Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-08-04

Filing date

2016-07-06

Publication date

2016-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43242604&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600219(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-07-06 Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh

2016-08-31 Publication of SMT201600219B publication Critical patent/SMT201600219B/en

Links

229940088597 hormone Drugs 0.000 title 1
239000005556 hormone Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gynecology & Obstetrics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pregnancy & Childbirth (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

SM201600219T 2010-08-04 2016-07-06 IMPROVED HUMAN FOLLICLE-STIMULATING HUMAN HORMONE SMT201600219B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PCT/EP2010/004769 WO2012016576A1 (en)	2010-08-04	2010-08-04	Improved recombinant human follicle-stimulating hormone
PCT/EP2011/063492 WO2012017058A1 (en)	2010-08-04	2011-08-04	Improved recombinant human follicle-stimulating hormone
EP11757190.1A EP2601210B1 (en)	2010-08-04	2011-08-04	Improved recombinant human follicle-stimulating hormone

Publications (1)

Publication Number	Publication Date
SMT201600219B true SMT201600219B (en)	2016-08-31

Family

ID=43242604

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201600219T SMT201600219B (en)	2010-08-04	2016-07-06	IMPROVED HUMAN FOLLICLE-STIMULATING HUMAN HORMONE

Country Status (27)

Country	Link
US (1)	US9527899B2 (en)
EP (2)	EP2601210B1 (en)
JP (2)	JP6001534B2 (en)
KR (1)	KR20130136448A (en)
CN (2)	CN106146646A (en)
AR (1)	AR082852A1 (en)
AU (1)	AU2011287525B2 (en)
BR (1)	BR112013004051A2 (en)
CA (1)	CA2805134C (en)
CU (1)	CU24043B1 (en)
CY (1)	CY1117778T1 (en)
DK (1)	DK2601210T3 (en)
EA (1)	EA029955B1 (en)
ES (2)	ES2576868T3 (en)
HR (1)	HRP20160671T1 (en)
HU (1)	HUE028357T2 (en)
IL (1)	IL223867B (en)
MX (1)	MX336489B (en)
NZ (1)	NZ604877A (en)
PL (1)	PL2601210T3 (en)
PT (1)	PT2601210T (en)
RS (1)	RS54905B1 (en)
SG (1)	SG186755A1 (en)
SI (1)	SI2601210T1 (en)
SM (1)	SMT201600219B (en)
WO (2)	WO2012016576A1 (en)
ZA (1)	ZA201209436B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (en)	2008-04-16	2015-06-21	Ferring Int Ct Sa	Pharmaceutical preparation
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
WO2012168680A1 (en)	2011-06-06	2012-12-13	Ferring B.V.	Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (en)	2011-08-08	2017-03-15	Ferring Bv	Composition for controlled ovarian stimulation
NZ707016A (en) *	2012-07-30	2017-08-25	Trophogen Inc	Glycoprotein hormone long-acting superagonists
CN104543416B (en) *	2013-10-09	2018-06-19	中国科学院大连化学物理研究所	A kind of functional monosaccharide feed for adjusting jenny reproductive performance and its application
CN103740754B (en) *	2013-10-25	2015-06-24	中国食品药品检定研究院	Mouse nerve growth factor-containing expression vector and cell
SG11201608132UA (en)	2014-04-18	2016-11-29	Glycotope Gmbh	Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
EP3091033A1 (en) *	2015-05-06	2016-11-09	Gamamabs Pharma	Anti-human-her3 antibodies and uses thereof
WO2017025566A1 (en) *	2015-08-10	2017-02-16	Glycotope Gmbh	Improved recombinant factor vii
BR112018003455A2 (en) *	2015-09-17	2018-09-25	Glycotope Gmbh	pharmaceutical composition or composition and use of the composition
CN106053861A (en) *	2016-07-28	2016-10-26	高常青	Follicle-stimulating hormonebiological activity intensity detection method
CA3160345A1 (en) *	2019-11-06	2021-05-14	The Regents Of The University Of Colorado, A Body Corporate	Modified follicle-stimulating hormone and methods of using the same
CN115433276B (en) *	2021-09-07	2024-04-02	苏州晟济药业有限公司	Mutant of VHH antibody or antigen fragment thereof and application thereof
WO2023215914A1 (en) *	2022-05-06	2023-11-09	The Regents Of The University Of Colorado, A Body Corporate	Modified follicle-stimulating hormone and methods of using the same
WO2024100549A1 (en) *	2022-11-08	2024-05-16	Oncogreen Therapeutics S.A.	Compounds for use in macrophage reprogramming
WO2024100548A1 (en) *	2022-11-08	2024-05-16	Oncogreen Therapeutics S.A.	Compound with anti-metastatic effect

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1176976T4 (en)	1999-05-07	2015-11-02	Serono Lab	Use of LH administered mid- or senfollikelfase for the treatment of anovulatory women
CA2464368A1 (en) *	2001-10-22	2003-05-01	Applied Research Systems Ars Holding N.V.	Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
CA2557725C (en) *	2004-02-13	2015-06-30	Glycotope Gmbh	Highly active glycoproteins-process conditions and an efficient method for their production
BRPI0716997B8 (en)	2006-09-10	2021-05-25	Glycotope Gmbh	protein or composition of protein molecules, methods for producing and using it
GB2459641B (en) *	2008-04-16	2012-06-27	Ubiquisys Ltd	Basestation power control
TWI488640B (en) *	2008-04-16	2015-06-21	Ferring Int Ct Sa	Pharmaceutical preparation
EP2325194A1 (en)	2009-11-24	2011-05-25	Glycotope GmbH	Process for the purification of glycoproteins
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone

2010
- 2010-08-04 WO PCT/EP2010/004769 patent/WO2012016576A1/en active Application Filing
2011
- 2011-08-04 EP EP11757190.1A patent/EP2601210B1/en not_active Revoked
- 2011-08-04 WO PCT/EP2011/063492 patent/WO2012017058A1/en active Application Filing
- 2011-08-04 EP EP16168841.1A patent/EP3075744B1/en not_active Revoked
- 2011-08-04 US US13/814,059 patent/US9527899B2/en active Active
- 2011-08-04 DK DK11757190.1T patent/DK2601210T3/en active
- 2011-08-04 EA EA201390194A patent/EA029955B1/en not_active IP Right Cessation
- 2011-08-04 ES ES11757190.1T patent/ES2576868T3/en active Active
- 2011-08-04 BR BR112013004051A patent/BR112013004051A2/en not_active Application Discontinuation
- 2011-08-04 SG SG2012093191A patent/SG186755A1/en unknown
- 2011-08-04 PT PT117571901T patent/PT2601210T/en unknown
- 2011-08-04 ES ES16168841T patent/ES2764083T3/en active Active
- 2011-08-04 JP JP2013522259A patent/JP6001534B2/en not_active Expired - Fee Related
- 2011-08-04 SI SI201130854A patent/SI2601210T1/en unknown
- 2011-08-04 CN CN201610363950.XA patent/CN106146646A/en active Pending
- 2011-08-04 KR KR1020137005553A patent/KR20130136448A/en not_active Application Discontinuation
- 2011-08-04 RS RS20160459A patent/RS54905B1/en unknown
- 2011-08-04 NZ NZ604877A patent/NZ604877A/en not_active IP Right Cessation
- 2011-08-04 AR ARP110102828A patent/AR082852A1/en unknown
- 2011-08-04 CN CN201180037096.3A patent/CN103068839B/en active Active
- 2011-08-04 MX MX2013000500A patent/MX336489B/en unknown
- 2011-08-04 AU AU2011287525A patent/AU2011287525B2/en not_active Ceased
- 2011-08-04 CA CA2805134A patent/CA2805134C/en not_active Expired - Fee Related
- 2011-08-04 HU HUE11757190A patent/HUE028357T2/en unknown
- 2011-08-04 PL PL11757190.1T patent/PL2601210T3/en unknown
2012
- 2012-12-12 ZA ZA2012/09436A patent/ZA201209436B/en unknown
- 2012-12-25 IL IL223867A patent/IL223867B/en active IP Right Grant
2013
- 2013-02-04 CU CU2013000019A patent/CU24043B1/en active IP Right Grant
2016
- 2016-06-13 HR HRP20160671TT patent/HRP20160671T1/en unknown
- 2016-06-16 CY CY20161100539T patent/CY1117778T1/en unknown
- 2016-06-24 JP JP2016125181A patent/JP2016168055A/en not_active Withdrawn
- 2016-07-06 SM SM201600219T patent/SMT201600219B/en unknown

Also Published As

Publication number	Publication date
BR112013004051A2 (en)	2016-07-05
NZ604877A (en)	2014-09-26
JP6001534B2 (en)	2016-10-05
KR20130136448A (en)	2013-12-12
CY1117778T1 (en)	2017-05-17
SG186755A1 (en)	2013-02-28
ES2764083T3 (en)	2020-06-02
WO2012017058A1 (en)	2012-02-09
AU2011287525A1 (en)	2013-01-17
EP2601210B1 (en)	2016-05-11
ES2576868T3 (en)	2016-07-11
PL2601210T3 (en)	2016-11-30
EP2601210A1 (en)	2013-06-12
IL223867B (en)	2018-04-30
EA201390194A1 (en)	2013-06-28
WO2012017058A8 (en)	2016-04-07
US20130137636A1 (en)	2013-05-30
SI2601210T1 (en)	2016-09-30
ZA201209436B (en)	2014-02-26
PT2601210T (en)	2016-07-07
MX336489B (en)	2016-01-21
CU24043B1 (en)	2014-11-27
US9527899B2 (en)	2016-12-27
CN103068839B (en)	2016-06-22
EP3075744A1 (en)	2016-10-05
JP2013535481A (en)	2013-09-12
CN103068839A (en)	2013-04-24
MX2013000500A (en)	2013-02-21
WO2012016576A1 (en)	2012-02-09
AR082852A1 (en)	2013-01-16
EP3075744B1 (en)	2019-12-18
DK2601210T3 (en)	2016-07-04
AU2011287525B2 (en)	2014-09-25
CA2805134A1 (en)	2012-02-09
EA029955B1 (en)	2018-06-29
CA2805134C (en)	2020-01-28
CN106146646A (en)	2016-11-23
JP2016168055A (en)	2016-09-23
HUE028357T2 (en)	2016-12-28
CU20130019A7 (en)	2013-05-31
RS54905B1 (en)	2016-10-31
HRP20160671T1 (en)	2016-09-23

Publication	Publication Date	Title
SMT201600219B (en)	2016-08-31	IMPROVED HUMAN FOLLICLE-STIMULATING HUMAN HORMONE
FR18C1043I2 (en)	2019-10-11	ANTIVIRAL THERAPY
HRP20181615T1 (en)	2018-12-14	Cytotoxicity-inducing therapeutic agent
DK2538984T3 (en)	2021-10-04	Compression bandage
EP2542086A4 (en)	2013-09-04	Compounds and therapeutic uses thereof
BR112012033478A2 (en)	2016-11-29	medical device
DK2539015T3 (en)	2016-04-04	retinal lESION
DK2525798T3 (en)	2017-11-20	ANESTHETIC FORMULATION
BR112014009634A2 (en)	2017-05-09	preparation and therapeutic agent
DK3162386T3 (en)	2020-01-02	Implantable medical devices
DK2652652T3 (en)	2020-02-17	MEDICINE ADMINISTRATION
DK2613888T3 (en)	2020-02-17	DOSAGE DEVICE
CU23987B1 (en)	2014-03-26	MEDICAL EQUIPMENT
GB201011411D0 (en)	2010-08-18	Therapeutic compounds and their use
DK2642980T3 (en)	2020-06-22	PEDIATRIC FORMULATION
DK2420219T3 (en)	2014-08-11	administration site
PL2536400T3 (en)	2015-04-30	Medicament comprising myramistin
IT1403226B1 (en)	2013-10-17	WATERPROOFING TREATMENT
IT1403367B1 (en)	2013-10-17	WIRELESS ELECTROMEDICAL DEVICE
FR2969180B1 (en)	2013-01-25	AMBULANT EXTENDER
DK2380545T3 (en)	2014-01-13	Therapy device
FI9030U1 (en)	2011-01-05	Joystick
UA21847S (en)	2011-05-25	BED "VENICE"
TH114583B (en)	2012-06-22	Syringe
GB201014918D0 (en)	2010-10-20	Therapeutic treatments